Retrospective analysis of treatment outcome and complications of patients with Multiple myeloma among patients treated at KFSHRC Jeddah in the period 2011 to 2024, A single center experience.
Introduction/Background/Significance: Multiple Myeloma (MM) is a Hematological malignancy of B-cell plasma cell that affects elderly population. It is the second most common malignancy after lymphoma. Little is known about the prevalence and presentation of this disease in Saudi Arabia. We are here reporting the retrospective analysis of treatment outcomes and complications among Saudi patients.
Materials and Methods/Case Presentation/Objective: In the period of January 1st 2011 till March 31st, 2024 all patients with MM were identified through our oncology data unit (ODU) after IRB approval (IRB 2023-94). A case reporting form was used (CRF) for data collection, and there is no conflict of interest.
Conclusions: Our data confirmed that our current management of patients with MM is matching the international standards, however, early detection of the disease to prevent late complications is needed. Future studies addressing the early diagnosis and interventions prospectively are needed.
